🇺🇸 FDA
Pipeline program

Placebo

0173

Phase 2 small_molecule terminated

Quick answer

Placebo for Crohn's Disease is a Phase 2 program (small_molecule) at Theravance Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Theravance Biopharma
Indication
Crohn's Disease
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials